News

ResistancePlus® GC receives CE-IVD mark

SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually …

Continue Reading

Johns Hopkins Medicine champions Mgen resistance testing for reproductive health in women

Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness …

Continue Reading

SpeeDx broaden European Distribution Network

SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and …

Continue Reading

Draft BASHH gonorrhoea guidelines recommend ciprofloxacin susceptibility testing

Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. …

Continue Reading

SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG

SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus MG. “This test is an …

Continue Reading

UK drafts new M. genitalium guidelines: Resistance Guided Therapy to tackle antibiotic resistance

The British Association of Sexual Health and HIV (BASHH) draft guidelines for Mycoplasma genitalium (Mgen) were posted for consultation and …

Continue Reading

ABC Radio National – Catriona Bradshaw discusses the success of Resistance Guided Therapy for treating M. genitalium

In her interview with Dr Norman Swan on ABC Radio National Health Report, Dr. Bradshaw discusses a new successful treatment …

Continue Reading

UK BASHH M. genitalium guidelines updated to include macrolide resistance testing

Important updates to the UK BASHH M. genitalium management guidelines are taking the issue of antimicrobial resistance (AMR) seriously. The …

Continue Reading

Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium

SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new …

Continue Reading

SpeeDx and Serosep sign UK and Ireland distribution agreement

SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will …

Continue Reading